Data AnalysisVerified
Reviewed and published by trentmaziarz, July 9, 2026. Discovered and drafted by our automated research pipeline.
Boston Scientific deployed HeartLogic, an AI algorithm built into implantable cardiac defibrillators and cardiac resynchronization therapy devices that predicts worsening heart failure events weeks before they occur. The algorithm continuously analyzes sensor data from the implanted device and alerts physicians when a patient's condition is deteriorating.
Details
HeartLogic became the first predictive analytic alert in an implantable device to receive FDA approval. The algorithm integrates data from multiple on-device sensors — including heart sounds, thoracic impedance, respiration rate, heart rate, and physical activity — into a single composite index score. Clinical validation in the MultiSENSE study demonstrated 70% sensitivity for detecting impending heart failure decompensation events, with alerts generated a mean of 34 days before the event. The system transmits alerts to clinicians via Boston Scientific's LATITUDE NXT remote patient management system.
Products affected
HeartLogicRESONATE ICDRESONATE CRT-DLATITUDE NXT Remote Patient Management System
Sources & Evidence
Company Disclosure
Cite this record
Trace Foundation. (2026). Boston Scientific: Boston Scientific deployed HeartLogic, an AI algorithm built into implantable cardiac defibrillators and cardiac resynchronization therapy devices that predicts worsening heart failure events weeks before they occur. The algorithm continuously analyzes sensor data from the implanted device and alerts physicians when a patient's condition is deteriorating (data as of 2026-07-09) [Data set record]. AI Trace. https://www.aitrace.org/r/practice/497fee12-b2eb-4d3f-bfbf-f34953368781. Accessed October 7, 2026.
- Stable link
- https://www.aitrace.org/r/practice/497fee12-b2eb-4d3f-bfbf-f34953368781
- Data as of
- July 9, 2026
- Last verified
- August 4, 2026
Other practices by Boston Scientific
RecommendationBoston Scientific integrated Coveo's AI-search platform into its B2B e-commerce site to deliver personalized search results, relevance tuning, and behavior-based product recommendations for healthcare facility buyers and sales representatives. The integration has been underway for approximately four years.Data AnalysisBoston Scientific deployed the AVVIGO+ Multi-Modality Guidance System, which includes an AI software feature called Automated Lesion Assessment that automatically identifies and measures coronary artery blockages during heart procedures. The system received FDA clearance in September 2023.Data AnalysisBoston Scientific deployed BeatLogic, a deep-learning algorithm that automatically analyzes ECG data from cardiac monitoring devices to detect and classify 34 distinct arrhythmias. The system processes over 3 billion heartbeats daily across patients in the United States and sends critical alerts to physicians.
Have evidence about Boston Scientific's AI practices? Submit a report.
Report a Sighting →